British Journal of Cancer - Table of Contents alert Volume 111 Issue 9

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 111, Issue 9 (1681-1880) Published online 28 October 2014 In this issue Editorial Minireviews Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Check out the Top 10 papers from the British Journal of Cancer!  British Journal of Cancer presents the top 10 downloaded papers for 2014. Halfway through the year, we've seen some excellent submissions to the journal. Yours could be next.   Click here to find out how you can submit your paper to British Journal of Cancer. Editorial Top Childhood leukaemia and nuclear installations: the long and winding road R Wakeford Br J Cancer 2014 111: 1681-1683; advance online publication, October 7, 2014; 10.1038/bjc.2014.517 Full Text Minireviews Top The impact of socioeconomic status on access to cancer clinical trials K Sharrocks, J Spicer, D R Camidge and S Papa Br J Cancer 2014 111: 1684-1687; advance online publication, August 5, 2014; 10.1038/bjc.2014.108 Abstract | Full Text Novel functions of chromatin-bound IκBα in oncogenic transformation L Espinosa, A Bigas and M C Mulero Br J Cancer 2014 111: 1688-1692; advance online publication, September 18, 2014; 10.1038/bjc.2014.84 Abstract | Full Text Clinical Studies Top Does the cancer drugs fund lead to faster uptake of cost-effective drugs? A time-trend analysis comparing England and Wales C Chamberlain, S M Collin, P Stephens, J Donovan, A Bahl and W Hollingworth Br J Cancer 2014 111: 1693-1702; advance online publication, February 25, 2014; 10.1038/bjc.2014.86 Abstract | Full Text Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality R Dobson, M I Burgess, J W Valle, D M Pritchard, J Vora, C Wong, C Chadwick, B Keevi, J Adaway, U Hofmann, G J Poston and D J Cuthbertson Br J Cancer 2014 111: 1703-1709; advance online publication, September 11, 2014; 10.1038/bjc.2014.468 Abstract | Full Text Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes K W Hagberg, K A McGlynn, V V Sahasrabuddhe and S Jick Br J Cancer 2014 111: 1710-1717; advance online publication, August 5, 2014; 10.1038/bjc.2014.447 Abstract | Full Text Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy K S Courneya, D C McKenzie, J R Mackey, K Gelmon, C M Friedenreich, Y Yasui, R D Reid, J R Vallerand, S C Adams, C Proulx, L B Dolan, E Wooding and R J Segal Br J Cancer 2014 111: 1718-1725; advance online publication, August 21, 2014; 10.1038/bjc.2014.466 Abstract | Full Text Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option D Meulendijks, L Dewit, N B Tomasoa, H van Tinteren, J H Beijnen, J H M Schellens and A Cats Br J Cancer 2014 111: 1726-1733; advance online publication, August 28, 2014; 10.1038/bjc.2014.467 Abstract | Full Text Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme B Kearns, S Whyte, J Chilcott and J Patnick Br J Cancer 2014 111: 1734-1741; advance online publication, September 2, 2014; 10.1038/bjc.2014.469 Abstract | Full Text Translational Therapeutics Top Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer K S Ramcharan, G Y H Lip, P S Stonelake and A D Blann Br J Cancer 2014 111: 1742-1749; advance online publication, September 11, 2014; 10.1038/bjc.2014.491 Abstract | Full Text Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo C L Schwab, S Bellone, D P English, D M Roque, S Lopez, E Cocco, R Nicoletti, I Bortolomai, E Bonazzoli, E Ratner, D-A Silasi, M Azodi, P E Schwartz, T J Rutherford and A D Santin Br J Cancer 2014 111: 1750-1756; advance online publication, September 30, 2014; 10.1038/bjc.2014.519 Abstract | Full Text PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer C Papadaki, M Sfakianaki, E Lagoudaki, G Giagkas, G Ioannidis, M Trypaki, E Tsakalaki, A Voutsina, A Koutsopoulos, D Mavroudis, V Georgoulias and J Souglakos Br J Cancer 2014 111: 1757-1764; advance online publication, September 18, 2014; 10.1038/bjc.2014.492 Abstract | Full Text Molecular Diagnostics Top microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma T O Yau, C W Wu, Y Dong, C-M Tang, S S M Ng, F K L Chan, J J Y Sung and J Yu Br J Cancer 2014 111: 1765-1771; advance online publication, September 18, 2014; 10.1038/bjc.2014.484 Abstract | Full Text Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies R Roy, D Zurakowski, J Wischhusen, C Frauenhoffer, S Hooshmand, M Kulke and M A Moses Br J Cancer 2014 111: 1772-1779; advance online publication, August 19, 2014; 10.1038/bjc.2014.462 Abstract | Full Text Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells B P Kaistha, T Honstein, V Müller, S Bielak, M Sauer, R Kreider, M Fassan, A Scarpa, C Schmees, H Volkmer, T M Gress and M Buchholz Br J Cancer 2014 111: 1780-1787; advance online publication, August 19, 2014; 10.1038/bjc.2014.460 Abstract | Full Text KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition H Hamidi, M Lu, K Chau, L Anderson, M Fejzo, C Ginther, R Linnartz, A Zubel, D J Slamon and R S Finn Br J Cancer 2014 111: 1788-1801; advance online publication, August 28, 2014; 10.1038/bjc.2014.475 Abstract | Full Text Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer K L Mahon, W Qu, J Devaney, C Paul, L Castillo, R J Wykes, M D Chatfield, M J Boyer, M R Stockler, G Marx, H Gurney, G Mallesara, P L Molloy, L G Horvath, S J Clark and PRIMe consortium Br J Cancer 2014 111: 1802-1809; advance online publication, August 21, 2014; 10.1038/bjc.2014.463 Abstract | Full Text Epidemiology Top Seasonal variation in the month of birth in patients with skin cancer F La Rosa, A Liso, F Bianconi, E Duca and F Stracci Br J Cancer 2014 111: 1810-1813; advance online publication, October 7, 2014; 10.1038/bjc.2014.522 Abstract | Full Text Updated investigations of cancer excesses in individuals born or resident in the vicinity of Sellafield and Dounreay K J Bunch, T J Vincent, R J Black, M S Pearce, R J Q McNally, P A McKinney, L Parker, A W Craft and M F G Murphy Br J Cancer 2014 111: 1814-1823; advance online publication, July 22, 2014; 10.1038/bjc.2014.357 Abstract | Full Text Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland K G J Pollock, K Kavanagh, A Potts, J Love, K Cuschieri, H Cubie, C Robertson, M Cruickshank, T J Palmer, S Nicoll and M Donaghy Br J Cancer 2014 111: 1824-1830; advance online publication, September 2, 2014; 10.1038/bjc.2014.479 Abstract | Full Text A survey study of women’s responses to information about overdiagnosis in breast cancer screening in Britain J Waller, K L Whitaker, K Winstanley, E Power and J Wardle Br J Cancer 2014 111: 1831-1835; advance online publication, August 28, 2014; 10.1038/bjc.2014.482 Abstract | Full Text Association of tamoxifen use and increased diabetes among Asian women diagnosed with breast cancer L-M Sun, H-J Chen, J-A Liang, T-C Li and C-H Kao Br J Cancer 2014 111: 1836-1842; advance online publication, September 16, 2014; 10.1038/bjc.2014.488 Abstract | Full Text Factors associated with timeliness of post-primary care referral, diagnosis and treatment for lung cancer: population-based, data-linkage study L F Forrest, J Adams, M White and G Rubin Br J Cancer 2014 111: 1843-1851; advance online publication, September 9, 2014; 10.1038/bjc.2014.472 Abstract | Full Text Aspirin and non-steroidal anti-inflammatory drug use and the risk of upper aerodigestive tract cancer T V Macfarlane, K Lefevre and M C Watson Br J Cancer 2014 111: 1852-1859; advance online publication, September 11, 2014; 10.1038/bjc.2014.473 Abstract | Full Text Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales A Linton, N Pavlakis, R O'Connell, M Soeberg, S Kao, S Clarke, J Vardy and N van Zandwijk Br J Cancer 2014 111: 1860-1869; advance online publication, September 4, 2014; 10.1038/bjc.2014.478 Abstract | Full Text Flavonoid and lignan intake in relation to bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study R Zamora-Ros, C Sacerdote, F Ricceri, E Weiderpass, N Roswall, G Buckland, D E St-Jules, K Overvad, C Kyrø, G Fagherazzi, M Kvaskoff, G Severi, J Chang-Claude, R Kaaks, U Nöthlings, A Trichopoulou, A Naska, D Trichopoulos, D Palli, S Grioni, A Mattiello, R Tumino, I T Gram, D Engeset, J M Huerta, E Molina-Montes, M Argüelles, P Amiano, E Ardanaz, U Ericson, B Lindkvist, L M Nilsson, L A Kiemeney, M Ros, H B Bueno-de-Mesquita, P H M Peeters, K-T Khaw, N J Wareham, V Knaze, I Romieu, A Scalbert, P Brennan, P Wark, P Vineis, E Riboli and C A González Br J Cancer 2014 111: 1870-1880; advance online publication, August 14, 2014; 10.1038/bjc.2014.459 Abstract | Full Text Advertisement British Journal of Cancer has you covered. The British Journal of Cancer publishes significant research that increases the understanding of the causes of cancer; informs about timely detection and accurate diagnosis; helps develop personalised therapy; and drives improvements in the treatment and survival of patients.  Subscribe today and don't miss a beat.   Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.